Twist Bioscience Corp financial data

Symbol
TWST on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
681 Gateway Blvd., South San Francisco, CA
State of incorporation
DE
Fiscal year end
September 30
Latest financial report
10-K - Q3 2024 - Nov 18, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 530 % -15.8%
Quick Ratio 41 % -19%
Debt-to-equity 27.2 % +19.8%
Return On Equity -39.5 % -31.8%
Return On Assets -31.1 % -27.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 59.4M shares
Common Stock, Shares, Outstanding 58.9M shares +2.29%
Entity Public Float 1.92B USD +130%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 58M shares +1.99%
Weighted Average Number of Shares Outstanding, Diluted 58M shares +1.99%

Income Statement

Label TTM Value / Value Unit Change %
Cost of Revenue 180M USD +15.6%
Research and Development Expense 90.9M USD -15%
Costs and Expenses 534M USD +15.5%
Operating Income (Loss) -221M USD -1.69%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -208M USD -2.31%
Income Tax Expense (Benefit) 560K USD -51.4%
Net Income (Loss) Attributable to Parent -209M USD -2.01%
Earnings Per Share, Basic -3.6 USD/shares 0%
Earnings Per Share, Diluted -3.6 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 226M USD -21%
Cash, Cash Equivalents, and Short-term Investments 289M USD -19.8%
Accounts Receivable, after Allowance for Credit Loss, Current 34.9M USD -20.8%
Inventory, Net 24.1M USD -24.9%
Assets, Current 347M USD -18.3%
Property, Plant and Equipment, Net 103M USD -22.2%
Operating Lease, Right-of-Use Asset 58.8M USD -17.8%
Goodwill 85.8M USD 0%
Other Assets, Noncurrent 3.09M USD -45.6%
Assets 614M USD -20.9%
Accounts Payable, Current 1.63M USD -88.4%
Employee-related Liabilities, Current 33.7M USD +30.3%
Accrued Liabilities, Current 15.1M USD +40.5%
Liabilities, Current 71M USD -3.16%
Operating Lease, Liability, Noncurrent 70.2M USD -11.3%
Other Liabilities, Noncurrent 407K USD -14.3%
Liabilities 142M USD -7.41%
Accumulated Other Comprehensive Income (Loss), Net of Tax -522K USD +31%
Retained Earnings (Accumulated Deficit) -1.24B USD -20.2%
Stockholders' Equity Attributable to Parent 473M USD -24.2%
Liabilities and Equity 614M USD -20.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23M USD +57.5%
Net Cash Provided by (Used in) Financing Activities -1.47M USD -273%
Net Cash Provided by (Used in) Investing Activities 4.17M USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 58.9M shares +2.29%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -20.2M USD +67%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 229M USD -20.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 361M USD +19.3%
Deferred Tax Assets, Gross 379M USD +13.3%
Operating Lease, Liability 85M USD
Depreciation 27.3M USD +13.3%
Payments to Acquire Property, Plant, and Equipment 1.51M USD -87.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -208M USD -2.44%
Lessee, Operating Lease, Liability, to be Paid 134M USD -10.1%
Property, Plant and Equipment, Gross 178M USD -2.37%
Operating Lease, Liability, Current 14.8M USD -0.61%
Lessee, Operating Lease, Liability, to be Paid, Year Two 13.9M USD -6.96%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.8M USD -0.31%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 48.5M USD -10.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.37M USD -39.8%
Deferred Tax Assets, Operating Loss Carryforwards 227M USD +8.42%
Unrecognized Tax Benefits 22.4M USD +16.8%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.47M USD +1.2%
Operating Lease, Payments 14.7M USD +0.71%
Additional Paid in Capital 1.72B USD +3.49%
Amortization of Intangible Assets 4.1M USD -22.6%
Depreciation, Depletion and Amortization 8.17M USD +54.4%
Deferred Tax Assets, Net of Valuation Allowance 18.2M USD -42.8%
Share-based Payment Arrangement, Expense 50.9M USD +68.2%
Interest Expense 2K USD -92.9%